内侧单髁与全膝关节置换治疗孤立性前内侧膝骨关节炎:350例双盲多中心随机试验的两年结果
这项双盲多中心优效性试验将350例严重前内侧膝骨关节炎患者随机分配至内侧单髁膝关节置换(mUKA)或全膝关节置换(TKA),比较两年内牛津膝关节评分(OKS)平均改善。mUKA在OKS改善上平均多3.5分(95%CI 2.3至4.7;p<0.001),但低于公认的最小临床重要差异(MCID)4至5分;12项次要结局中10项 favoring mUKA,其中遗忘关节评分、活动度、KOOS症状评分和SF-36躯体疼痛评分达到MCID。两组翻修率和死亡率无差异,非翻修再手术率mUKA为2.3%、TKA为6.9%。
要点
- mUKA在OKS改善上仅比TKA多3.5分,未达MCID,不构成明确临床优效。
- 遗忘关节评分、活动度、KOOS症状评分和SF-36躯体疼痛评分 favoring mUKA且达MCID。
- 非翻修再手术率mUKA 2.3%低于TKA 6.9%,翻修率和死亡率无差异。
核心结论
- 两年随访显示mUKA在OKS差异上未达明确临床优效,但多项患者报告结局和活动度 favoring mUKA且具临床意义。
- 总体而言mUKA与TKA短期结果相似,mUKA有小幅优势。
研究设计与样本
- 双盲、多中心、优效性随机对照试验,在10个关节置换中心招募严重前内侧膝骨关节炎患者。
- 2017年9月至2021年3月共随机350例:mUKA组177例(79女,98男;平均年龄67.7±7.5岁),TKA组173例(84女,89男;平均年龄66.7±7.8岁)。
- 主要结局为两年内牛津膝关节评分(OKS)平均改善,按意向性分析。
- 次要结局包括多项患者报告结局;死亡、翻修和其他再手术作为严重不良事件分析。
主要发现
- 两年OKS平均改善mUKA组优于TKA组3.5分(95%CI 2.3至4.7;p<0.001),但低于MCID 4至5分。
- 12项次要结局中10项 favoring mUKA,其余2项无显著性差异。
- 遗忘关节评分(FJS)差异14.1(95%CI 9.5至18.6)、前两年活动度差异7.0°(95%CI 5.3°至8.7°)、两年时活动度差异5.5°(95%CI 3.6°至7.4°)、KOOS症状评分差异10.3(95%CI 7.8至12.8)、SF-36躯体疼痛评分差异7.6(95%CI 4.1至11.1)均 favoring mUKA且达到MCID。
- 非翻修再手术:mUKA组4例(2.3%),TKA组12例(6.9%),差异4.7%(95%CI 0.2%至9.8%);TKA组12例中9例行麻醉下手法松解。
- 翻修率和死亡率两组无差异。
临床怎么用
- 对于孤立性前内侧膝骨关节炎,mUKA与TKA均可获得良好短期结果,mUKA在遗忘关节评分、活动度、症状和疼痛方面有小幅临床优势。
- OKS差异未达MCID,不应仅凭OKS宣称mUKA优效;需结合多项患者报告结局综合判断。
- mUKA非翻修再手术率较低,TKA组再手术多因麻醉下手法松解,选择术式时可考虑此差异。
局限性
- 原文未报告局限性内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The superiority of medial unicompartmental knee arthroplasty (mUKA) versus total knee arthroplasty (TKA) for isolated anteromedial knee osteoarthritis (AMOA) remains a subject of ongoing debate. We present the 2-year results of a multicenter, randomized trial comparing the patient-reported and clinical outcomes of these 2 implant types in the treatment of AMOA. METHODS: This double-blinded superiority trial recruited patients with severe AMOA at 10 arthroplasty centers and randomized them to undergo either mUKA or TKA. The primary outcome was the average improvement in the Oxford Knee Score (OKS) over 2 years, analyzed by intention-to-treat. A range of patient-reported outcomes served as secondary outcomes. Death, revision, and other reoperations were analyzed as serious adverse events (SAEs). RESULTS: Between September 2017 and March 2021, 350 patients were randomized: 177 (79 female, 98 male; mean age, 67.7 ± 7.5 years) to mUKA and 173 (84 female, 89 male; mean age, 66.7 ± 7.8 years) to TKA. The average 2-year OKS improvement differed by 3.5 points (95% CI, 2.3 to 4.7; p < 0.001) in favor of mUKA, although this difference was below the generally accepted minimal clinically important difference (MCID) of 4 to 5 points. Ten of the 12 secondary outcomes favored mUKA, while the remaining 2 were nonsignificant. The differences in the Forgotten Joint Score (FJS) (14.1; 95% CI, 9.5 to 18.6), range of motion during the first 2 years (7.0°; 95% CI, 5.3° to 8.7°) and at 2 years (5.5°; 95% CI, 3.6° to 7.4°), Knee injury and Osteoarthritis Outcome Score (KOOS) symptoms score (10.3; 95% CI, 7.8 to 12.8), and Short Form-36 (SF-36) bodily pain score (7.6; 95% CI, 4.1 to 11.1) all favored mUKA and reached the MCID. Non-revision reoperations were performed in 4 patients (2.3%) after mUKA and in 12 patients (6.9%) after TKA (9 of the 12 underwent manipulation under anesthesia); the difference was 4.7% (95% CI, 0.2% to 9.8%). There were no differences in the rates of revision or death between the groups. CONCLUSIONS: Averaged over the 2-year follow-up, mUKA demonstrated minor advantages that did not achieve clear clinical superiority on the basis of the OKS difference. However, the FJS, range of motion, KOOS symptoms score, and SF-36 bodily pain score all demonstrated differences in favor of mUKA that were clinically meaningful. The overall findings suggest that mUKA and TKA yield similarly favorable short-term results, with small advantages for mUKA. LEVEL OF EVIDENCE: Therapeutic Level I . See Instructions for Authors for a complete description of levels of evidence.
引用
- Mortensen JF, Blanche P, Blom CS, et al. Medial Unicompartmental Versus Total Knee Arthroplasty in the Treatment of Isolated Anteromedial Knee Osteoarthritis: Two-Year Results from a Double-Blinded, Multicenter, Randomized Trial of 350 Patients. J Bone Joint Surg Am. 2026. PMID: 41662451. doi:10.2106/JBJS.25.00612
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。